Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

2.14
-0.0500-2.28%
Post-market: 2.150.0092+0.43%19:30 EDT
Volume:2.00M
Turnover:4.36M
Market Cap:178.49M
PE:-1.53
High:2.31
Open:2.21
Low:2.10
Close:2.19
52wk High:5.55
52wk Low:1.03
Shares:83.41M
Float Shares:70.69M
Volume Ratio:0.83
T/O Rate:2.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:15.60
PE(LYR):-1.67

Loading ...

Pyxis Oncology Prices Unregistered Private Placement at USD 50 Million

Reuters
·
Jul 03

Pyxis Oncology is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jul 02

Pyxis Oncology Posts Corporate Deck Outlining Strategy to Build Differentiated Antibody-drug Conjugate Company Around MICVO Program in Head and Neck Cancer

Reuters
·
Jun 30

Pyxis Oncology announces up to $114M private placement

TIPRANKS
·
Jun 30

Guggenheim Sticks to Its Buy Rating for Pyxis Oncology (PYXS)

TIPRANKS
·
Jun 30

Pyxis Oncology Prices USD 50 Million Private Placement at USD 2.55 a Share

Reuters
·
Jun 30

Pyxis Oncology - Expects Updated Phase 1 Monotherapy Data in Fall 2026 and Phase 1/2 Data in Q4 2026

THOMSON REUTERS
·
Jun 30

Pyxis Oncology - Sells 19.6 Mln Shares at $2.55 Each with Warrants at $3.29 Exercise Price

THOMSON REUTERS
·
Jun 30

Pyxis Oncology: Financing Led by Bvf Partners L.p. with Participation from Gordonmd Global Investments, Rtw Investments, & Coastlands Capital

THOMSON REUTERS
·
Jun 30

Pyxis Oncology - Upfront Proceeds Expected to Extend Cash Runway into Q2 2027

THOMSON REUTERS
·
Jun 30

Pyxis Oncology Announces up to $114 Million Private Placement Financing to Advance Micvo Through Key Clinical Milestones

THOMSON REUTERS
·
Jun 30

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

GlobeNewswire
·
Jun 30

Penny Stocks To Watch For Growth In June 2026

Simply Wall St.
·
Jun 19

Pyxis Oncology Stockholders Approve Directors and Auditor Slate

TIPRANKS
·
Jun 16

Pyxis Oncology holds annual shareholder meeting via webcast

Reuters
·
Jun 16

Pyxis Oncology (PYXS) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 23

Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS) and Actuate Therapeutics, Inc. (ACTU)

TIPRANKS
·
May 18

Analysts Conflicted on These Healthcare Names: Aquestive Therapeutics (AQST), Pyxis Oncology (PYXS) and Biogen (BIIB)

TIPRANKS
·
May 15

RBC Capital Keeps Their Buy Rating on Pyxis Oncology (PYXS)

TIPRANKS
·
May 15

Pyxis Oncology (PYXS) Gets a Buy from Guggenheim

TIPRANKS
·
May 15